| Zacks Company Profile for West Pharmaceutical Services, Inc. (WST : NYSE) |
|
|
| |
| • Company Description |
| West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Number of Employees: 10,600 |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $221.22 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 677,827 shares |
| Shares Outstanding: 71.85 (millions) |
| Market Capitalization: $15,893.63 (millions) |
| Beta: 1.09 |
| 52 Week High: $352.33 |
| 52 Week Low: $187.43 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
4.63% |
0.32% |
| 12 Week |
8.69% |
-4.76% |
| Year To Date |
-32.46% |
-36.21% |
|
|
|
|
| |
|
|
| |
| • General Corporate Information |
Officers
Eric M. Green - President; Chief Executive Officer and Chair of th
Bernard J. Birkett - Senior Vice President; Chief Financial Officer
Chad R. Winters - Vice President; Finance & Chief Accounting Officer
Mark A. Buthman - Director
William F. Feehery - Director
|
|
Peer Information
West Pharmaceutical Services, Inc. (ITRJ)
West Pharmaceutical Services, Inc. (BRLI.)
West Pharmaceutical Services, Inc. (GOGY)
West Pharmaceutical Services, Inc. (PSTX.)
West Pharmaceutical Services, Inc. (ELGXQ)
West Pharmaceutical Services, Inc. (CAH)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED/DENTAL-SUPP
Sector: Medical
CUSIP: 955306105
SIC: 3841
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 07/24/25
|
|
Share - Related Items
Shares Outstanding: 71.85
Most Recent Split Date: 9.00 (2.00:1)
Beta: 1.09
Market Capitalization: $15,893.63 (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 0.38% |
| Current Fiscal Quarter EPS Consensus Estimate: $1.62 |
Indicated Annual Dividend: $0.84 |
| Current Fiscal Year EPS Consensus Estimate: $6.28 |
Payout Ratio: 0.13 |
| Number of Estimates in the Fiscal Year Consensus: 6.00 |
Change In Payout Ratio: 0.02 |
| Estmated Long-Term EPS Growth Rate: 6.47% |
Last Dividend Paid: 04/30/2025 - $0.21 |
| Next EPS Report Date: 07/24/25 |
|
|
|
| |
